Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.

Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.5.2 was added and v3.5.0 was removed in the page history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision v3.5.0 was added and revision v3.4.3 was removed from the study record history.SummaryDifference0.1%

- Check49 days agoChange DetectedThe version history now lists Revision: v3.4.3 as the latest entry and removes Revision: v3.4.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.4.2 was added to the record history, and previous notices about funding lapse and revision v3.4.1 were removed as administrative updates to the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check84 days agoChange DetectedA site-wide notice about government funding delays was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check91 days agoChange DetectedGlossary display and color-legend indicators for additions and deletions were added; No FEAR Act data labeling updated, and the revision tag changed from v3.3.4 to v3.4.0.SummaryDifference0.8%

Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.